Gene Therapy

Aims & Scope

Gene Therapy covers both the research and clinical applications of novel therapeutic techniques based on a genetic component.

Over the last few decades, significant advances in technologies ranging from identifying novel genetic targets that cause disease through to clinical studies, which show therapeutic benefit, have elevated this multidisciplinary field to the forefront of modern medicine.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	4.5
2024	4.60

SJR (SCImago Journal Rank)

Year	Value
2024	1.784

Quartile

Year	Value
2024	Q1

h-index

Year	Value
2024	177

Journal Rank

Year	Value
2024	1760

Journal Citation Indicator

Year	Value
2024	1179

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Medline
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Biochemistry, Genetics and Molecular Biology, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Plat-E: an efficient and stable system for transient packaging of retroviruses

  Citation: 1479

  Authors: S, T, T

• Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA

  Citation: 1436

  Authors: F, Y K, D

• Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield

  Citation: 1120

  Authors: S, B J, E, I, M, K, C, R J, N

• PEGylated DNA/transferrin–PEI complexes: reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery

  Citation: 1022

  Authors: M, S, S, R, E

• Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial

  Citation: 798

  Authors: J M, M D, S D, G Y, T, W D, C A, F, C, F, R L

• Gene Therapy Progress and Prospects: Nonviral vectors

  Citation: 783

  Authors: T, L

• Magnetofection: enhancing and targeting gene delivery by magnetic force in vitro and in vivo

  Citation: 770

  Authors: F, M, U, J, C, A, B, C

• The influence of polymer structure on the interactions of cationic polymers with DNA and morphology of the resulting complexes

  Citation: 687

  Authors: MX, FC

• ICP34.5 deleted herpes simplex virus with enhanced oncolytic, immune stimulating, and anti-tumour properties

  Citation: 665

  Authors: B L, M, Z-Q, R H, C, P, Y, S K, M, P, C A, R S

• Self-complementary recombinant adeno-associated virus (scAAV) vectors promote efficient transduction independently of DNA synthesis

  Citation: 583

  Authors: DM, PE, RJ

---